National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Clin Trials. 2009 Aug;6(4):386-91. doi: 10.1177/1740774509341482. Epub 2009 Jul 22.
A clinical research protocol document must reflect both sound scientific rationale as well as local, national and, when applicable, international regulatory and human subject protections requirements. These requirements originate from a variety of sources, undergo frequent revision and are subject to interpretation. Tools to assist clinical investigators in the production of clinical protocols could facilitate navigating these requirements and ultimately increase the efficiency of clinical research.
The National Institute of Allergy and Infectious Diseases (NIAID) developed templates for investigators to serve as the foundation for protocol development. These protocol templates are designed as tools to support investigators in developing clinical protocols.
NIAID established a series of working groups to determine how to improve its capacity to conduct clinical research more efficiently and effectively. The Protocol Template Working Group was convened to determine what protocol templates currently existed within NIAID and whether standard NIAID protocol templates should be produced. After review and assessment of existing protocol documents and requirements, the group reached consensus about required and optional content, determined the format and identified methods for distribution as well as education of investigators in the use of these templates.
The templates were approved by the NIAID Executive Committee in 2006 and posted as part of the NIAID Clinical Research Toolkit [1] website for broad access. These documents require scheduled revisions to stay current with regulatory and policy changes.
The structure of any clinical protocol template, whether comprehensive or specific to a particular study phase, setting or design, affects how it is used by investigators. Each structure presents its own set of advantages and disadvantages. While useful, protocol templates are not stand-alone tools for creating an optimal protocol document, but must be complemented by institutional resources and support. Education and guidance of investigators in the appropriate use of templates is necessary to ensure a complete yet concise protocol document. Due to changing regulatory requirements, clinical protocol templates cannot become static, but require frequent revisions.
临床研究方案文件必须既反映合理的科学依据,又要符合当地、国家和适用的国际法规以及保护人类受试者的要求。这些要求来自各种来源,经常修订,并需要进行解释。帮助临床研究人员编写临床方案的工具可以帮助他们更好地应对这些要求,最终提高临床研究的效率。
美国国立过敏和传染病研究所(NIAID)开发了模板,供研究人员作为方案开发的基础。这些方案模板旨在作为支持研究人员开发临床方案的工具。
NIAID 成立了一系列工作组,以确定如何提高其更高效和有效地进行临床研究的能力。方案模板工作组的成立旨在确定 NIAID 内部目前存在哪些方案模板,以及是否应该制定标准的 NIAID 方案模板。在审查和评估现有方案文件和要求后,该小组就所需和可选内容达成共识,确定了格式,并确定了分发方法以及研究人员使用这些模板的教育方法。
这些模板于 2006 年获得 NIAID 执行委员会的批准,并作为 NIAID 临床研究工具包[1]网站的一部分广泛发布,以便于获取。这些文件需要定期修订,以跟上法规和政策的变化。
任何临床方案模板的结构,无论是全面的还是特定于特定的研究阶段、环境或设计,都会影响研究人员对其的使用。每种结构都有其自身的优缺点。虽然这些模板很有用,但它们并不是创建理想方案文件的独立工具,而是必须辅以机构资源和支持。必须对研究人员进行模板使用的教育和指导,以确保方案文件完整而简洁。由于法规要求不断变化,临床方案模板不能保持静态,需要频繁修订。